Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance are bridging laboratory sciences and patient care to provide the most precise treatment options for patients with cancer. Patients world-wide are benefiting from these efforts.
Collectively, these leading cancer research and clinical care organizations are enhancing our knowledge of cancer using population research, preclinical cancer biology, translational, imaging and clinical studies of solid tumors and hematologic cancers.
Seattle Translational Tumor Research (STTR) creates environments which enable researchers and clinicians to accelerate scientific discovery and translate it into cures for patients; and has established programs addressing a number of cancers: bladder, brain, breast, colon, head and neck, leukemia, liver, lymphoma, myelodysplastic/ myeloproliferative disease, lung, myeloma, ovary, pancreas, prostate, sarcoma, and skin.
Learn more about STTR.